SUSQUEHANNA INTERNATIONAL GROUP, LLP - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 2 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$151,118,000
+625.1%
1,625,980
+364.6%
0.01%
+66.7%
Q3 2021$20,842,000
+58.8%
349,995
+81.9%
0.00%
+50.0%
Q2 2021$13,122,000
-16.3%
192,395
-14.9%
0.00%
-33.3%
Q1 2021$15,685,000
-64.5%
226,059
-60.7%
0.00%0.0%
Q4 2020$44,214,000
+53.2%
575,472
+49.1%
0.00%
-40.0%
Q3 2020$28,856,000
+25.9%
385,839
+6.0%
0.01%
-16.7%
Q2 2020$22,915,000
+113.6%
364,037
+42.5%
0.01%
+50.0%
Q1 2020$10,727,000
-39.3%
255,404
-34.4%
0.00%
-20.0%
Q4 2019$17,679,000
+1.9%
389,222
+2.7%
0.01%
-16.7%
Q3 2019$17,353,000
-75.2%
379,149
-68.3%
0.01%
-33.3%
Q2 2019$70,057,000
+407.3%
1,194,884
+287.9%
0.01%
+50.0%
Q1 2019$13,811,000
+95.6%
308,072
+70.0%
0.01%
+100.0%
Q4 2018$7,060,000
-57.6%
181,248
-49.9%
0.00%
-40.0%
Q3 2018$16,663,000
-12.9%
362,090
-17.5%
0.01%
-28.6%
Q2 2018$19,138,000
-23.9%
438,954
-31.0%
0.01%
-22.2%
Q1 2018$25,139,000
-14.1%
636,433
-26.1%
0.01%
-10.0%
Q4 2017$29,252,000
+37.3%
861,122
+3.1%
0.01%
+25.0%
Q3 2017$21,298,000
+77.9%
835,200
+17.7%
0.01%
+60.0%
Q2 2017$11,974,000709,8000.01%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 4,190,000$321,918,0005.54%
Prosight Management, LP 145,700$11,194,0005.17%
Integral Health Asset Management, LLC 200,000$15,366,0004.57%
Copernicus Capital Management, LLC 3,740$287,0004.47%
GREAT POINT PARTNERS LLC 345,120$26,516,0004.31%
Asymmetry Capital Management, L.P. 101,245$7,779,0003.55%
First Light Asset Management, LLC 321,967$24,737,0001.83%
DAFNA Capital Management LLC 76,815$5,902,0001.76%
SECTORAL ASSET MANAGEMENT INC 320,059$24,590,0001.73%
Nicholas Investment Partners, LP 276,633$21,254,0001.64%
View complete list of ARENA PHARMACEUTICALS INC shareholders